Clinical Trial Update: A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Sage-217 plus an antidepressant to placebo plus an antidepressant in adults with major depressive disorder; study completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Antidepressant (ADT) (unspecified antidepressant)
• SAGE-217 (zuranolone)

Snippet

Sponsor: Biogen | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED | Results posted: 2023-11-07